Pfizer
PFE
PFE
1,988 hedge funds and large institutions have $152B invested in Pfizer in 2016 Q2 according to their latest regulatory filings, with 125 funds opening new positions, 819 increasing their positions, 836 reducing their positions, and 83 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% less call options, than puts
Call options by funds: $2.54B | Put options by funds: $2.54B
2% less repeat investments, than reductions
Existing positions increased: 819 | Existing positions reduced: 836
3.51% less ownership
Funds ownership: 78.68% → 75.17% (-3.5%)
Holders
1,988
Holding in Top 10
286
Calls
$2.54B
Puts
$2.54B
Top Buyers
| 1 | +$788M | |
| 2 | +$359M | |
| 3 | +$228M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$218M |
| 5 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$206M |
Top Sellers
| 1 | -$2.37B | |
| 2 | -$1.46B | |
| 3 | -$943M | |
| 4 |
CM
Corvex Management
New York
|
-$520M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$480M |